{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:07:08Z","timestamp":1790662028280,"version":"4.1.0"},"reference-count":253,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004789","name":"John Fell Fund, University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KA\/4594\/2-1"],"award-info":[{"award-number":["KA\/4594\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00835","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T05:07:01Z","timestamp":1574312821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?"],"prefix":"10.3389","volume":"10","author":[{"given":"Alexei M.","family":"Bygrave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasyoka","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri M.","family":"Kullmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Bannerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"K\u00e4tzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"155cm11","DOI":"10.1126\/scitranslmed.3003142","article-title":"Revolution Stalled","volume":"4","author":"Hyman","year":"2012","journal-title":"Sci Transl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12888-014-0351-3","article-title":"A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia","volume":"14","author":"Downing","year":"2014","journal-title":"BMC Psychiatry"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/758212","article-title":"Pomaglumetad methionil (LY2140023 Monohydrate) and Aripiprazole in patients with Schizophrenia: a Phase 3, Multicenter, double-blind comparison","volume-title":"Schizophr Res Treat","author":"Adams","year":"2014"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.08.020","article-title":"Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo","volume":"150","author":"Stauffer","year":"2013","journal-title":"Schizophr Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-244X-13-143","article-title":"phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia","volume":"13","author":"Adams","year":"2013","journal-title":"BMC Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30344-3","article-title":"Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme","volume":"3","author":"Bugarski-Kirola","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.2159","article-title":"Add-on Treatment of Benzoate for Schizophrenia: a randomized, double-blind, placebo-controlled trial of d-amino acid oxidase inhibitor","volume":"70","author":"Lane","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA Receptor and Schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr Bull"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs069","article-title":"Has an Angel Shown the Way? Etiological and therapeutic implications of the PCP\/NMDA model of schizophrenia","volume":"38","author":"Javitt","year":"2012","journal-title":"Schizophr Bull"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs100","article-title":"Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet","volume":"38","author":"Javitt","year":"2012","journal-title":"Schizophr Bull"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2017.06.006","article-title":"Mapping the consequences of impaired synaptic plasticity in schizophrenia through development: an integrative model for diverse clinical features","volume":"21","author":"Forsyth","year":"2017","journal-title":"Trends Cognit Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00553-2","article-title":"Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach","volume":"3","author":"Ruderfer","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.171","article-title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database","volume":"40","author":"Allen","year":"2008","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.137","article-title":"Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia","volume":"18","author":"Weickert","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsycho.2015.10.013","article-title":"A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: how can we link molecular abnormalities to mismatch negativity deficits","volume":"116","author":"Catts","year":"2016","journal-title":"Biol Psychol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/YPG.0000000000000216","article-title":"In-silico investigation of coding variants potentially affecting the functioning of the glutamatergic N-methyl-D-aspartate receptor in schizophrenia","volume":"29","author":"Tsavou","year":"2019","journal-title":"Psychiatr Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10519-018-9893-3","article-title":"Weighted burden analysis of exome-sequenced case-control sample implicates synaptic genes in Schizophrenia aetiology","volume":"48","author":"Curtis","year":"2018","journal-title":"Behav Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3639-07.2008","article-title":"NMDA Receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory","volume":"28","author":"Bannerman","year":"2008","journal-title":"J Neurosci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1530-7","article-title":"Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for \u201cNMDA antagonist modelling\u201d of schizophrenia","volume":"205","author":"Gilmour","year":"2009","journal-title":"Psychopharmacol (Berl)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s0028-3908(02)00402-1","article-title":"Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition","volume":"44","author":"Higgins","year":"2003","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2246-z","article-title":"Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning","volume":"216","author":"Dalton","year":"2011","journal-title":"Psychopharmacol (Berl)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2277-5","article-title":"A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory","volume":"217","author":"Smith","year":"2011","journal-title":"Psychopharmacol (Berl)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.123","article-title":"The role of GluN2A and GluN2B subunits on the effects of NMDA receptor antagonists in modeling Schizophrenia and treating refractory depression","volume":"39","author":"Jim\u00e9nez-S\u00e1nchez","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2016.05.025","article-title":"Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment","volume":"311","author":"Higgins","year":"2016","journal-title":"Behav Brain Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00213-005-2203-9","article-title":"Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat","volume":"179","author":"Higgins","year":"2005","journal-title":"Psychopharmacol (Berl)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fpsyt.2018.00566","article-title":"Combination of G72 genetic variation and g72 protein level to detect Schizophrenia: machine learning approaches","volume":"9","author":"Lin","year":"2018","journal-title":"Front Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopsych.2010.09.012","article-title":"Reduced dysbindin expression mediates N-Methyl-D-Aspartate receptor hypofunction and impaired working memory performance","volume":"69","author":"Karlsgodt","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.05.041","article-title":"Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of Schizophrenia patients","volume":"98","author":"Weickert","year":"2008","journal-title":"Schizophr Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nm1418","article-title":"Altered neuregulin 1\u2013erbB4 signaling contributes to NMDA< receptor hypofunction in schizophrenia","volume":"12","author":"Hahn","year":"2006","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.03.028","article-title":"The neuregulin-1 receptor ErbB4 controls glutamatergic synapse maturation and plasticity","volume":"54","author":"Li","year":"2007","journal-title":"Neuron"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4314-06.2007","article-title":"Neuregulin1 (NRG1) signaling through fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+\/\u2013 Knock-Outs compared with wild-type mice","volume":"27","author":"Bjarnadottir","year":"2007","journal-title":"J Neurosci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.mp.4001434","article-title":"Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia","volume":"9","author":"Hashimoto","year":"2004","journal-title":"Mol Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602002103","article-title":"Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5\u2032 SNPs associated with the disease","volume":"103","author":"Law","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1038\/ncomms8222","article-title":"A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2\/ErbB4 signalling","volume":"6","author":"Vullhorst","year":"2015","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.22","article-title":"Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders","volume":"23","author":"Yan","year":"2018","journal-title":"Mol Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby003","article-title":"Schizophrenia-like dopamine release abnormalities in a mouse model of NMDA receptor hypofunction","volume":"45","author":"Nakao","year":"2019","journal-title":"Schizophr Bull"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D 2 and serotonin 5-HT 2 receptors\u2014implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Mol Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001682","article-title":"Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics","volume":"10","author":"Seeman","year":"2005","journal-title":"Mol Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20561","article-title":"Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia","volume":"62","author":"Seeman","year":"2008","journal-title":"Synap N Y N"},{"key":"B45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/syn.20647","article-title":"Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil","volume":"63","author":"Seeman","year":"2009","journal-title":"Synap N Y N"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145700002091","article-title":"Role of serotonergic 5-HT2A receptors in the psychotomimetic actions of phencyclidine","volume":"3","author":"Rabin","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/syn.890160107","article-title":"RTI-4793-14, a new ligand with high affinity and selectivity for the (+)-MK801-insensitive [3H]1-]1-(2-thienyl)cyclohexyl]piperidine binding site (PCP site 2) of guinea pig brain","volume":"16","author":"Goodman","year":"1994","journal-title":"Synap N Y N"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059334","article-title":"The ketamine analogue methoxetamine and 3- and 4-Methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor","volume":"8","author":"Roth","year":"2013","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-018-0083-8","article-title":"NMDAR-independent, cAMP-dependent antidepressant actions of ketamine","volume-title":"Mol Psychiatry","author":"Wray","year":"2018"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-Induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00976-8","article-title":"Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia","volume":"48","author":"Kegeles","year":"2000","journal-title":"Biol Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in Schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/070674376100600307","article-title":"Observations on the action of Sernyl-a new psychotropic drug","volume":"6","author":"Ban","year":"1961","journal-title":"Can Psychiatr Assoc J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs011","article-title":"Phencyclidine\/Schizophrenia: one view toward the past, the other to the future","volume":"38","author":"Domino","year":"2012","journal-title":"Schizophr Bull"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug; sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.07.022","article-title":"N-Methyl-D-Aspartate Receptor antagonist effects on prefrontal cortical connectivity better model early than chronic Schizophrenia","volume":"77","author":"Anticevic","year":"2015","journal-title":"Biol Psychiatry"},{"key":"B60","article-title":"Neurodevelopmental consequences of early exposure to phencyclidine and related drugs","volume":"21","author":"Deutsch","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2006.09.001","article-title":"Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia","volume":"53","author":"du Bois","year":"2007","journal-title":"Brain Res Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0165-0173(00)00018-7","article-title":"Roles of NMDA receptor activity and nitric oxide production in brain development","volume":"32","author":"Contestabile","year":"2000","journal-title":"Brain Res Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00081.2017","article-title":"Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats","volume":"118","author":"Kjaerby","year":"2017","journal-title":"J Neurophysiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2011.10.052","article-title":"Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research","volume":"227","author":"Lim","year":"2012","journal-title":"Behav Brain Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113494107","article-title":"Psychiatry\u2019s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders","volume":"27","author":"Carhart-Harris","year":"2013","journal-title":"J Psychopharmacol (Oxf)"},{"key":"B66","doi-asserted-by":"crossref","DOI":"10.1213\/00000539-195809000-00007","article-title":"A study of a 1-aryl cyclo hexyl amine for anesthesia*","volume":"37","author":"Greifenstein","year":"1958","journal-title":"Anesth Analg"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-015-0027-5","article-title":"Ketamin als An\u00e4sthetikum bei der Elektrokrampftherapie","volume":"64","author":"Janke","year":"2015","journal-title":"Anaesthesist"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1038\/tp.2012.69","article-title":"GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction","volume":"2","author":"Gandal","year":"2012","journal-title":"Transl Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2012.00767.x","article-title":"GluN1 hypomorph mice exhibit wide-ranging behavioral alterations","volume":"11","author":"Barkus","year":"2012","journal-title":"Genes Brain Behav"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to Schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1159\/000337984","article-title":"Preweaning sensorimotor deficits and adolescent hypersociability in grin1 knockdown mice","volume":"34","author":"Moy","year":"2012","journal-title":"Dev Neurosci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.150938","article-title":"Novel environment and GABA agonists alter event-related potentials in N-Methyl-d-aspartate NR1 hypomorphic and wild-type mice","volume":"331","author":"Bodarky","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2009.00504.x","article-title":"Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for Schizophrenia","volume":"8","author":"Halene","year":"2009","journal-title":"Genes Brain Behav"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2012.00816.x","article-title":"Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia","volume":"11","author":"Gandal","year":"2012","journal-title":"Genes Brain Behav"},{"key":"B76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic Anti\u2013N-methyl-D-aspartate receptor encephalitis associated with Ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2174\/157340011797183184","article-title":"Anti-NMDA Receptor encephalitis in psychiatry","volume":"7","author":"Kayser","year":"2011","journal-title":"Curr Psychiatry Rev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41537-016-0003-3","article-title":"Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia","volume":"3","author":"Nakazawa","year":"2017","journal-title":"NPJ Schizophr"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of Anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti\u2013N-Methyl-D-Aspartate Receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann Neurol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300411","article-title":"Cognitive deficits following anti-NMDA receptor encephalitis","volume":"83","author":"Finke","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2010.09.012","article-title":"Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis","volume":"231","author":"Wandinger","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnhum.2011.00069","article-title":"Imaging of thalamocortical dysrhythmia in neuropsychiatry","volume":"5","author":"Schulman","year":"2011","journal-title":"Front Hum Neurosci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","article-title":"Bitopertin in negative symptoms of Schizophrenia\u2014Results from the phase III FlashLyte and DayLyte studies","volume":"82","author":"Bugarski-Kirola","year":"2017","journal-title":"Biol Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2165\/11586650-000000000-00000","article-title":"Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia","volume":"25","author":"Singh","year":"2011","journal-title":"CNS Drugs"},{"key":"B90","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fpsyt.2018.00537","article-title":"Multidimensional connectomics and treatment-resistant Schizophrenia: linking phenotypic circuits to targeted therapeutics","volume":"9","author":"MacKay","year":"2018","journal-title":"Front Psychiatry"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2010.00656.x","article-title":"Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology","volume":"10","author":"DeVito","year":"2011","journal-title":"Genes Brain Behav"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.9.4926","article-title":"d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor","volume":"97","author":"Mothet","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1996.75.1.311","article-title":"Glycine at the NMDA receptor in cat visual cortex: saturation and changes with age","volume":"75","author":"Czepita","year":"1996","journal-title":"J Neurophysiol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.12880","article-title":"d-amino acid oxidase knockout (Dao \u2013\/\u2013) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption","volume":"41","author":"Pritchett","year":"2015","journal-title":"Eur J Neurosci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13192","article-title":"Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao \u2013\/\u2013) mice","volume":"43","author":"Pritchett","year":"2016","journal-title":"Eur J Neurosci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.171","article-title":"Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology","volume":"17","author":"Stone","year":"2012","journal-title":"Mol Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.0442","article-title":"Nature of glutamate alterations in Schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies","volume":"73","author":"Merritt","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B98","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuron.2013.02.011","article-title":"Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver","volume":"78","author":"Schobel","year":"2013","journal-title":"Neuron"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA Receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308455101","article-title":"NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex","volume":"101","author":"Jackson","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphysparis.2013.06.002","article-title":"The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia","volume":"107","author":"Jodo","year":"2013","journal-title":"J Physiol-Paris"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0465-5","article-title":"Landscape of ribosome-engaged transcript isoforms reveals extensive neuronal-cell-class-specific alternative splicing programs","volume":"22","author":"Furlanis","year":"2019","journal-title":"Nat Neurosci"},{"key":"B103","volume-title":"SPLICECODE DATABASE.","author":"Scheiffele","year":"2019"},{"key":"B104","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1124\/mol.116.105130","article-title":"GluN2D-Containing N-methyl-d-Aspartate Receptors mediate synaptic transmission in hippocampal interneurons and regulate interneuron activity","volume":"90","author":"Perszyk","year":"2016","journal-title":"Mol Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00329","article-title":"A novel negative allosteric modulator selective for GluN2C\/2D-containing NMDA receptors inhibits synaptic transmission in hippocampal interneurons","volume":"9","author":"Swanger","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"B106","first-page":"9","article-title":"GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice","volume-title":"Front Cell Neurosci","author":"von Engelhardt","year":"2015"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3703-08.2009","article-title":"Mg2+ imparts NMDA receptor subtype selectivity to the alzheimer\u2019s drug memantine","volume":"29","author":"Kotermanski","year":"2009","journal-title":"J Neurosci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coph.2006.08.011","article-title":"NMDA receptor subunits: function and pharmacology","volume":"7","author":"Paoletti","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-11-03549.1996","article-title":"Multiple structural elements determine subunit specificity of Mg2+ Block in NMDA Receptor channels","volume":"16","author":"Kuner","year":"1996","journal-title":"J Neurosci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0654-5","article-title":"Shared and distinct transcriptomic cell types across neocortical areas","volume":"563","author":"Tasic","year":"2018","journal-title":"Nature"},{"key":"B111","unstructured":"RNA-Seq Mouse Data Navigator:: Allen Brain Atlas: Cell Types2018"},{"key":"B112","article-title":"NR1 and NR2 Subunit Contributions to N-Methyl-d-aspartate Receptor channel blocker pharmacology","volume":"280","author":"Monaghan","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199306000-00021","article-title":"Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists","volume":"4","author":"Yamakura","year":"1993","journal-title":"Neuroreport"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1203-16.2016","article-title":"The role of GluN2C-containing NMDA receptors in ketamine\u2019s psychotogenic action and in Schizophrenia models","volume":"36","author":"Khlestova","year":"2016","journal-title":"J Neurosci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013722","article-title":"Essential role of NMDA receptor channel \u03b54 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine","volume":"5","author":"Hagino","year":"2010","journal-title":"PloS One"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.230391","article-title":"GluN2D N-Methyl-d-Aspartate Receptor subunit contribution to the stimulation of brain activity and gamma oscillations by Ketamine: implications for Schizophrenia","volume":"356","author":"Sapkota","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1017\/S146114570900042X","article-title":"Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex","volume":"12","author":"Xi","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113645","article-title":"Cystine\/Glutamate antiporter and aripiprazole compensate NMDA antagonist-induced dysfunction of thalamocortical L-Glutamatergic transmission","volume":"19","author":"Fukuyama","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/biom9060234","article-title":"Clozapine Normalizes a Glutamatergic transmission abnormality induced by an impaired NMDA Receptor in the thalamocortical pathway via the Activation of a Group III Metabotropic Glutamate Receptor","volume":"9","author":"Fukuyama","year":"2019","journal-title":"Biomolecules"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhh168","article-title":"Activation of medial prefrontal cortex by phencyclidine is mediated via a Hippocampo-prefrontal pathway","volume":"15","author":"Jodo","year":"2005","journal-title":"Cereb Cortex"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e00457","DOI":"10.1002\/prp2.457","article-title":"Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc\u2013","volume":"7","author":"Okada","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5328.953","article-title":"Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of Phencyclidine","volume":"277","author":"Jentsch","year":"1997","journal-title":"Science"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00034-1","article-title":"Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat","volume":"17","author":"Jentsch","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1038\/tp.2017.198","article-title":"Ketamine: differential neurophysiological dynamics in functional networks in the rat brain","volume":"7","author":"Ahnaou","year":"2017","journal-title":"Transl Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.2414","article-title":"Deficits in prefrontal cortical and extrastriatal dopamine release in Schizophrenia: a positron emission tomographic functional magnetic resonance imaging study","volume":"72","author":"Slifstein","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B126","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2018.09.031","article-title":"Parvalbumin loss following chronic sub-anesthetic NMDA antagonist treatment is age-dependent in the hippocampus: Implications for modeling NMDA hypofunction","volume-title":"bioRxiv","author":"Honeycutt","year":"2018"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.08.029","article-title":"A pharmacological model for psychosis based on N-methyl-D-aspartate Receptor hypofunction: molecular, cellular, functional and behavioral abnormalities","volume":"59","author":"Rujescu","year":"2006","journal-title":"Biol Psychiatry"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.05.005","article-title":"Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism","volume":"97","author":"Braun","year":"2007","journal-title":"Schizophr Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0269881107067097","article-title":"Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat","volume":"21","author":"Abdul-Monim","year":"2007","journal-title":"J Psychopharmacol (Oxf)"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1126\/science.1148045","article-title":"Ketamine-induced loss of phenotype of fast-spiking interneurons Is mediated by NADPH-Oxidase","volume":"318","author":"Behrens","year":"2007","journal-title":"Science"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2004.03.039","article-title":"Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia","volume":"126","author":"Keilhoff","year":"2004","journal-title":"Neuroscience"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2010.11.043","article-title":"Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers","volume":"488","author":"Benneyworth","year":"2011","journal-title":"Neurosci Lett"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2016-0050","article-title":"Subchronic administration of phencyclidine produces hypermethylation in the parvalbumin gene promoter in rat brain","volume":"8","author":"Fachim","year":"2016","journal-title":"Epigenomics"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-15-06315.2003","article-title":"gene expression deficits in a subclass of gaba neurons in the prefrontal cortex of subjects with Schizophrenia","volume":"23","author":"Hashimoto","year":"2003","journal-title":"J Neurosci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1523\/JNEUROSCI.3748-04.2005","article-title":"Developmental changes in parvalbumin regulate presynaptic Ca2+ Signaling","volume":"25","author":"Collin","year":"2005","journal-title":"J Neurosci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00576.2002","article-title":"Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus","volume":"89","author":"Vreugdenhil","year":"2003","journal-title":"J Neurophysiol"},{"key":"B138","first-page":"5","article-title":"Neuregulin 1 Type I overexpression is associated with reduced NMDA Receptor\u2013Mediated synaptic signaling in hippocampal interneurons expressing PV or CCK","volume-title":"eNeuro","author":"Kotzadimitriou","year":"2018"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nature08928","article-title":"Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling","volume":"464","author":"Fazzari","year":"2010","journal-title":"Nature"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(03)00157-X","article-title":"Large variability in synaptic n-methyl-d-aspartate receptor density on interneurons and a comparison with pyramidal-cell spines in the rat hippocampus","volume":"119","author":"Ny\u00cdri","year":"2003","journal-title":"Neuroscience"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3459","article-title":"Developmental origin dictates interneuron AMPA and NMDA receptor subunit composition and plasticity","volume":"16","author":"Matta","year":"2013","journal-title":"Nat Neurosci"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2012.245852","article-title":"Input-specific learning rules at excitatory synapses onto hippocampal parvalbumin-expressing interneurons","volume":"591","author":"Roux","year":"2013","journal-title":"J Physiol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49872","article-title":"Dendritic NMDA receptors in parvalbumin neurons enable strong and stable neuronal assemblies","volume":"8","author":"Cornford","year":"2019","journal-title":"Elife"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033813","article-title":"Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia","volume":"14","author":"Lewis","year":"2008","journal-title":"Neurotox Res"},{"key":"B145","article-title":"Alterations in cortical interneurons and cognitive function in schizophrenia","volume-title":"Neurobiol Dis","author":"Dienel","year":"2018"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.7.649","article-title":"Density of glutamic acid decarboxylase 67 messenger rna\u2013containing neurons that express the n-methyl-d-aspartate receptor subunit nr2a in the anterior cingulate cortex in schizophrenia and bipolar disorder","volume":"61","author":"Woo","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11010052","article-title":"Cortical deficits of glutamic acid decarboxylase 67 expression in Schizophrenia: clinical, protein, and cell type-specific features","volume":"168","author":"Curley","year":"2011","journal-title":"Am J Psychiatry"},{"key":"B148","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in Schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.14081031","article-title":"In vivo measurement of GABA transmission in healthy subjects and Schizophrenia patients","volume":"172","author":"Frankle","year":"2015","journal-title":"Am J Psychiatry"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nature12866","article-title":"Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning","volume":"504","author":"Donato","year":"2013","journal-title":"Nature"},{"key":"B151","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-244X-9-71","article-title":"Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia","volume":"9","author":"Bitanihirwe","year":"2009","journal-title":"BMC Psychiatry"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.04.034","article-title":"N-Methyl-D-Aspartate Receptor and calbindin-containing neurons in the anterior cingulate cortex in Schizophrenia and bipolar disorder","volume":"64","author":"Woo","year":"2008","journal-title":"Biol Psychiatry"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol Psychiatry"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci Lett"},{"key":"B155","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/schbul\/sbl033","article-title":"Elevations of endogenous kynurenic acid produce spatial working memory deficits","volume":"33","author":"Chess","year":"2007","journal-title":"Schizophr Bull"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.39","article-title":"Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior","volume":"35","author":"Potter","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.11.017","article-title":"Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity","volume":"247","author":"Kegel","year":"2017","journal-title":"Psychiatry Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.05.011","article-title":"Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of Schizophrenia","volume":"62","author":"Grace","year":"2012","journal-title":"Neuropharmacology"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2847-07.2007","article-title":"Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia","volume":"27","author":"Lodge","year":"2007","journal-title":"J Neurosci"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2204-14.2014","article-title":"Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia","volume":"34","author":"Nguyen","year":"2014","journal-title":"J Neurosci"},{"key":"B161","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-018-0341-9","article-title":"NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity","volume-title":"Mol Psychiatry","author":"Picard","year":"2019"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316488111","article-title":"Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition","volume":"111","author":"Gilani","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B163","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41398-018-0268-6","article-title":"Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity","volume":"8","author":"Grimm","year":"2018","journal-title":"Transl Psychiatry"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300678","article-title":"Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists","volume":"30","author":"Chartoff","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/bf01258633","article-title":"The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice","volume":"75","author":"Carlsson","year":"1989","journal-title":"J Neural Transm"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.038422","article-title":"The Group II metabotropic glutamate receptor agonist (\u2013)-2-Oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats","volume":"303","author":"Swanson","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)91671-E","article-title":"The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study","volume":"612","author":"Steinpreis","year":"1993","journal-title":"Brain Res"},{"key":"B168","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.07.005","article-title":"Abnormal gamma oscillations in N-Methyl-D-Aspartate receptor hypofunction models of Schizophrenia","volume":"79","author":"Jadi","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B170","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.schres.2014.12.026","article-title":"The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia","volume":"167","author":"Cohen","year":"2015","journal-title":"Schizophr Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.31","article-title":"A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior","volume":"17","author":"Carl\u00e9n","year":"2012","journal-title":"Mol Psychiatry"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2018.01.018","article-title":"Presynaptic Effects of N-Methyl-D-Aspartate Receptors enhance parvalbumin cell\u2013mediated inhibition of pyramidal cells in mouse prefrontal cortex","volume":"84","author":"Pafundo","year":"2018","journal-title":"Biol Psychiatry"},{"key":"B173","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nn.2447","article-title":"Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes","volume":"13","author":"Belforte","year":"2010","journal-title":"Nat Neurosci"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.07.031","article-title":"The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes","volume":"59","author":"Butt","year":"2008","journal-title":"Neuron"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1038\/tp.2016.44","article-title":"Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801","volume":"6","author":"Bygrave","year":"2016","journal-title":"Transl Psychiatry"},{"key":"B176","first-page":"12","article-title":"Gene-environment interaction in a conditional NMDAR-Knockout model of Schizophrenia","volume-title":"Front Behav Neurosci","author":"Bygrave","year":"2019"},{"key":"B177","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/aur.1264","article-title":"Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes","volume":"6","author":"Saunders","year":"2013","journal-title":"Autism Res Off J Int Soc Autism Res"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.7","article-title":"Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits","volume":"39","author":"Billingslea","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083879","article-title":"Mice Lacking NMDA Receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists","volume":"9","author":"Pozzi","year":"2014","journal-title":"PloS One"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.09.017","article-title":"NMDA Receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory","volume":"68","author":"Korotkova","year":"2010","journal-title":"Neuron"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.12.004","article-title":"Social isolation exacerbates Schizophrenia-like phenotypes via Oxidative Stress in Cortical Interneurons","volume":"73","author":"Jiang","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B182","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.neuron.2007.01.031","article-title":"Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior","volume":"53","author":"Fuchs","year":"2007","journal-title":"Neuron"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2751","article-title":"Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory","volume":"14","author":"Murray","year":"2011","journal-title":"Nat Neurosci"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1371\/journal.pbio.0030159","article-title":"A Developmental switch in the response of DRG neurons to ETS transcription factor signaling","volume":"3","author":"Hippenmeyer","year":"2005","journal-title":"PloS Biol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature07991","article-title":"Parvalbumin neurons and gamma rhythms enhance cortical circuit performance","volume":"459","author":"Sohal","year":"2009","journal-title":"Nature"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05312.x","article-title":"Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus","volume":"25","author":"Niewoehner","year":"2007","journal-title":"Eur J Neurosci"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601758103","article-title":"Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum","volume":"103","author":"Dang","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81827-9","article-title":"The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory","volume":"87","author":"Tsien","year":"1996","journal-title":"Cell"},{"key":"B189","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1017\/s1092852900022240","article-title":"Could stress cause psychosis in individuals vulnerable to Schizophrenia","volume":"7","author":"Corcoran","year":"2002","journal-title":"CNS Spectr"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/nature09563","article-title":"The environment and schizophrenia","volume":"468","author":"van Os","year":"2010","journal-title":"Nature"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2013.04.010","article-title":"Genes and environments in schizophrenia: the different pieces of a manifold puzzle","volume":"37","author":"R\u00e9thelyi","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/23.1.119","article-title":"Patient attributes and expressed emotion as risk factors for psychotic relapse","volume":"23","author":"Linszen","year":"1997","journal-title":"Schizophr Bull"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291700036655","article-title":"Expressed emotion as a predictor of schizophrenic relapse: an analysis of aggregated data","volume":"20","author":"Parker","year":"1990","journal-title":"Psychol Med"},{"key":"B194","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1521\/psyc.67.2.197.35959","article-title":"Expressed emotion, attribution, and control in parents of Schizophrenic patients","volume":"67","author":"Peterson","year":"2004","journal-title":"Psychiatry Interpers Biol Process"},{"key":"B195","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fnbeh.2013.00116","article-title":"Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia","volume":"7","author":"Jiang","year":"2013","journal-title":"Front Behav Neurosci"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr Opin Neurobiol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.mp.4000789","article-title":"Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia","volume":"6","author":"Herken","year":"2001","journal-title":"Mol Psychiatry"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2015.19","article-title":"Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis","volume":"17","author":"Hardingham","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3453","article-title":"Magnetic resonance spectroscopy study of the antioxidant defense system in Schizophrenia","volume":"15","author":"Matsuzawa","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.07.028","article-title":"Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia","volume":"83","author":"Cabungcal","year":"2014","journal-title":"Neuron"},{"key":"B202","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuropharm.2009.06.002","article-title":"Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex","volume":"57","author":"Behrens","year":"2009","journal-title":"Neuropharmacology"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(02)02245-2","article-title":"Cysteine regulation of protein function \u2013 as exemplified by NMDA-receptor modulation","volume":"25","author":"Lipton","year":"2002","journal-title":"Trends Neurosci"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1038\/nn2071","article-title":"Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses","volume":"11","author":"Papadia","year":"2008","journal-title":"Nat Neurosci"},{"key":"B205","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1038\/ncomms7761","article-title":"Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system","volume":"6","author":"Baxter","year":"2015","journal-title":"Nat Commun"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300454110","article-title":"Perineuronal nets protect fast-spiking interneurons against oxidative stress","volume":"110","author":"Cabungcal","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.47","article-title":"Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia","volume":"22","author":"Steullet","year":"2017","journal-title":"Mol Psychiatry"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1038\/srep37580","article-title":"Developmental disruption of perineuronal nets in the medial prefrontal cortex after maternal immune activation","volume":"6","author":"Paylor","year":"2016","journal-title":"Sci Rep"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.4907","article-title":"How Nox2-Containing NADPH oxidase affects cortical Circuits in the NMDA receptor antagonist model of Schizophrenia","volume":"18","author":"Wang","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"B210","article-title":"Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a \u201ccentral hub\u201d in schizophrenia pathophysiology","volume-title":"Schizophr Res","author":"Steullet","year":"2014"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4457-08.2008","article-title":"Interleukin-6 mediates the increase in NADPH-Oxidase in the ketamine model of Schizophrenia","volume":"28","author":"Behrens","year":"2008","journal-title":"J Neurosci"},{"key":"B212","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","article-title":"Developmental neuroinflammation and schizophrenia","volume":"42","author":"Meyer","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B213","article-title":"Pharmacology of NMDA Receptors","volume-title":"Biology of the NMDA Receptor. Front in Neurosci","author":"Monaghan","year":""},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1124\/mol.51.6.1015","article-title":"Differential sensitivity of RecombinantN-Methyl-d-Aspartate Receptor subtypes to zinc inhibition","volume":"51","author":"Chen","year":"1997","journal-title":"Mol Pharmacol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-15-05711.1997","article-title":"High-affinity zinc inhibition of NMDA NR1\u2013NR2A Receptors","volume":"17","author":"Paoletti","year":"1997","journal-title":"J Neurosci"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00007.2017","article-title":"Hippocampal GABAergic inhibitory interneurons","volume":"97","author":"Pelkey","year":"2017","journal-title":"Physiol Rev"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen","year":"2016","journal-title":"World J Psychiatry"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1038\/319774a0","article-title":"Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5","volume":"319","author":"Morris","year":"1986","journal-title":"Nature"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1038\/378182a0","article-title":"Distinct components of spatial learning revealed by prior training and NMDA receptor blockade","volume":"378","author":"Bannerman","year":"1995","journal-title":"Nature"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3677","article-title":"Hippocampal synaptic plasticity, spatial memory and anxiety","volume":"15","author":"Bannerman","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1038\/378186a0","article-title":"Spatial learning without NMDA receptor-dependent long-term potentiation","volume":"378","author":"Saucier","year":"1995","journal-title":"Nature"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071795","article-title":"Requirement for Hippocampal CA3 NMDA Receptors in associative memory recall","volume":"297","author":"Nakazawa","year":"2002","journal-title":"Science"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00165-X","article-title":"Hippocampal CA3 NMDA Receptors are crucial for memory acquisition of one-time experience","volume":"38","author":"Nakazawa","year":"2003","journal-title":"Neuron"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0640-10.2010","article-title":"Loss of GluN2B-Containing NMDA Receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning","volume":"30","author":"Brigman","year":"2010","journal-title":"J Neurosci"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3408-05.2006","article-title":"Impaired sequential egocentric and allocentric memories in forebrain-Specific\u2013NMDA receptor knock-out mice during a new task dissociating strategies of navigation","volume":"26","author":"Rondi-Reig","year":"2006","journal-title":"J Neurosci"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3166","article-title":"Dissecting spatial knowledge from spatial choice by hippocampal NMDA receptor deletion","volume":"15","author":"Bannerman","year":"2012","journal-title":"Nat Neurosci"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81828-0","article-title":"Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice","volume":"87","author":"McHugh","year":"1996","journal-title":"Cell"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.06.026","article-title":"Pyramidal cell selective ablation of N-Methyl-D-Aspartate Receptor 1 causes increase in cellular and network excitability","volume":"77","author":"Tatard-Leitman","year":"2015","journal-title":"Biol Psychiatry"},{"key":"B229","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2014.10.037","article-title":"Effects of prefrontal cortex and hippocampal NMDA NR1-subunit deletion on complex cognitive and social behaviors","volume":"1600","author":"Finlay","year":"2015","journal-title":"Brain Res"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061278","article-title":"Contribution of NMDA Receptor hypofunction in prefrontal and cortical excitatory neurons to Schizophrenia-like phenotypes","volume":"8","author":"Rompala","year":"2013","journal-title":"PloS One"},{"key":"B231","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nlm.2014.12.012","article-title":"Prefrontal NMDA receptors expressed in excitatory neurons control fear discrimination and fear extinction","volume":"119","author":"Vieira","year":"2015","journal-title":"Neurobiol Learn Mem"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3457","article-title":"GluN2B in corticostriatal circuits governs choice learning and choice shifting","volume":"16","author":"Brigman","year":"2013","journal-title":"Nat Neurosci"},{"key":"B233","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat Genet"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.09.039","article-title":"Contribution of hippocampal and extra-hippocampal NR2B-Containing NMDA Receptors to performance on spatial learning tasks","volume":"60","author":"von Engelhardt","year":"2008","journal-title":"Neuron"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2560\/12\/1\/016007","article-title":"A comparative study of event-related coupling patterns during an auditory oddball task in schizophrenia","volume":"12","author":"Bachiller","year":"2015","journal-title":"J Neural Eng"},{"key":"B237","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.schres.2014.12.018","article-title":"Resting-state theta-band connectivity and verbal memory in schizophrenia and in the high-risk state","volume":"161","author":"Andreou","year":"2015","journal-title":"Schizophr Res"},{"key":"B238","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0010-440X(95)90103-5","article-title":"A neurocomputational approach to delusions","volume":"36","author":"Spitzer","year":"1995","journal-title":"Compr Psychiatry"},{"key":"B239","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am J Psychiatry"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.91","article-title":"What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit","volume":"19","author":"Barkus","year":"2014","journal-title":"Mol Psychiatry"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2014.04.038","article-title":"NMDA receptor hypofunction and the thalamus in schizophrenia","volume":"131","author":"Vukadinovic","year":"2014","journal-title":"Physiol Behav"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.01.008","article-title":"T-type calcium channels: From molecule to therapeutic opportunities","volume":"108","author":"Weiss","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1002\/cne.22567","article-title":"Low-threshold calcium channel subunit Ca(v) 3.3 is specifically localized in GABAergic neurons of rodent thalamus and cerebral cortex","volume":"519","author":"Liu","year":"2011","journal-title":"J Comp Neurol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1038\/srep34233","article-title":"A rare schizophrenia risk variant of CACNA1I disrupts Cav3.3 channel activity","volume":"6","author":"Andrade","year":"2016","journal-title":"Sci Rep"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0925-4927(97)00071-1","article-title":"Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons","volume":"82","author":"Danos","year":"1998","journal-title":"Psychiatry Res"},{"key":"B246","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00001756-200001170-00020","article-title":"Parvalbumin-immunoreactive neurons in the human anteroventral thalamic nucleus","volume":"11","author":"Dixon","year":"2000","journal-title":"Neuroreport"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scog.2017.02.001","article-title":"NMDAR hypofunction and somatostatin-expressing GABAergic interneurons and receptors: a newly identified correlation and its effects in schizophrenia","volume":"8","author":"Alherz","year":"2017","journal-title":"Schizophr Res Cognit"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1500450112","article-title":"Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area","volume":"112","author":"Krabbe","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.05.028","article-title":"Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors","volume":"59","author":"Zweifel","year":"2008","journal-title":"Neuron"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813415106","article-title":"Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior","volume":"106","author":"Zweifel","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2808","article-title":"Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety","volume":"14","author":"Zweifel","year":"2011","journal-title":"Nat Neurosci"},{"key":"B252","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrn2536","article-title":"Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia","volume":"10","author":"Fletcher","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"B253","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/npjschz.2016.3","article-title":"Early interventions in risk groups for schizophrenia: what are we waiting for","volume":"2","author":"Sommer","year":"2016","journal-title":"NPJ Schizophr"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00835\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T05:07:12Z","timestamp":1574312832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00835\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":253,"alternative-id":["10.3389\/fpsyt.2019.00835"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00835","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"article-number":"835"}}